Anti-Human CD38 Antibody |
101-M306 |
ReliaTech |
100 µg |
EUR 399 |
Description: CD38 is a type II transmembrane protein that functions as a signaling molecule and mediates the adhesion between lymphocytes and endothelial cells. It also functions enzymatically in the formation and hydrolyzation of the second messenger cyclic ADP ribose. In the hematopoietic system, CD38 is most highly expressed on plasma cells. |
Human IgG antibody Laboratories manufactures the invivogen anti-cd38 reagents distributed by Genprice. The Invivogen Anti-Cd38 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Invivogen products are available in stock. Specificity: Invivogen Category: Anti-Cd38
anti- CD38 antibody |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against CD38 |
anti- CD38 antibody |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against CD38 |
Anti-CD38 antibody |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: The protein encoded by this gene is a non-lineage-restricted, type II transmembrane glycoprotein that synthesizes and hydrolyzes cyclic adenosine 5'-diphosphate-ribose, an intracellular calcium ion mobilizing messenger. The release of soluble protein and the ability of membrane-bound protein to become internalized indicate both extracellular and intracellular functions for the protein. This protein has an N-terminal cytoplasmic tail, a single membrane-spanning domain, and a C-terminal extracellular region with four N-glycosylation sites. Crystal structure analysis demonstrates that the functional molecule is a dimer, with the central portion containing the catalytic site. It is used as a prognostic marker for patients with chronic lymphocytic leukemia. Alternative splicing results in multiple transcript variants. |
Anti-CD38 antibody |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: The protein encoded by this gene is a non-lineage-restricted, type II transmembrane glycoprotein that synthesizes and hydrolyzes cyclic adenosine 5'-diphosphate-ribose, an intracellular calcium ion mobilizing messenger. The release of soluble protein and the ability of membrane-bound protein to become internalized indicate both extracellular and intracellular functions for the protein. This protein has an N-terminal cytoplasmic tail, a single membrane-spanning domain, and a C-terminal extracellular region with four N-glycosylation sites. Crystal structure analysis demonstrates that the functional molecule is a dimer, with the central portion containing the catalytic site. It is used as a prognostic marker for patients with chronic lymphocytic leukemia. Alternative splicing results in multiple transcript variants. |
Anti-CD38 antibody |
St John's Laboratory |
50 µg |
EUR 409.2 |
Description: CD38 is a type II transmembrane protein that functions as a signalling molecule and mediates the adhesion between lymphocytes and endothelial cells. In the hematopoietic system, CD38 is mostly highly expressed on plasma cells all pre-B lymphocytes and thymocytes. The antigen is expressed during the early stages of T- and B-lymphocytes differentiation and on most of CD34+ cells. CD38 is a counter-receptor of CD31. Clone HB7 (HB7, THB-7) comes from ATCC. |
Chemicals information
Anti-mIL-1β-mIgG1 InvivoFit™ |
mil1b-mab9-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mCTLA4-mIgG2a InvivoFit™ |
mctla4-mab10-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-mCTLA4-mIgG2a InvivoFit™ |
mctla4-mab10-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mCTLA4-mIgG2a InvivoFit™ |
mctla4-mab10-50 |
InvivoGen FR |
50 mg |
EUR 5208 |
Anti-mTIGIT-mIgG2a InvivoFit™ |
mtigit-mab10-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-mTIGIT-mIgG2a InvivoFit™ |
mtigit-mab10-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mIL-2-mIgG1e3 InvivoFit™ |
mil2-mab15-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |
Anti-mIL-28b-mIgG1 InvivoFit™ |
mil28b-mab9-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |
Anti-mIL-6-mIgG1e3 InvivoFit™ |
mil6-mab15-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |
Anti-mIL-6-mIgG1e3 InvivoFit™ |
mil6-mab15-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mPD-1-mIgG1e3 InvivoFit™ |
mpd1-mab15-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-mPD-1-mIgG1e3 InvivoFit™ |
mpd1-mab15-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-mPD-1-mIgG1e3 InvivoFit™ |
mpd1-mab15-50 |
InvivoGen FR |
50 mg |
EUR 5208 |
Anti-PD-L1-mIgG1e3 InvivoFit™ |
pdl1-mab15-1 |
InvivoGen FR |
1 mg |
EUR 353.85 |
Anti-PD-L1-mIgG1e3 InvivoFit™ |
pdl1-mab15-10 |
InvivoGen FR |
10 mg |
EUR 2285.85 |
Anti-PD-L1-mIgG1e3 InvivoFit™ |
pdl1-mab15-50 |
InvivoGen FR |
50 mg |
EUR 5208 |
Anti-mIL-16-mIgG1e3 InvivoFit™ |
mil16-mab15-1 |
InvivoGen FR |
1 mg |
EUR 628.95 |